Could a simple drug make brain aneurysm surgery safer?
NCT ID NCT06238115
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving the drug tirofiban during stent or flow diverter procedures for unruptured brain aneurysms could reduce the number of small brain injuries seen on MRI after surgery. 192 adults aged 18-80 took part. The goal was to see if tirofiban works better than standard blood-thinning therapy at preventing clots and strokes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FLOW DIVERTER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tiantan Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which brain aneurysm treatment is safer? a Head-to-Head test
- Can 4D-MRI spot brain aneurysms before they rupture?
- Brain aneurysm repair: Stent-Assisted coiling put to the test
- Brain aneurysm showdown: which coated stent causes fewer strokes?
- Which anesthesia is safer for brain aneurysm repair? new study investigates
- Brain aneurysm study aims to predict rupture risk without surgery